ProCE Banner Activity

Optimizing Precision Medicine for Patients With Lung and Thyroid Cancer: Guidance for the Multidisciplinary Team


Download these slides from an interdisciplinary workshop series to get up to date on the latest data informing optimal biomarker testing and targeted treatment strategies for lung or thyroid cancers harboring a RET alteration or NTRK fusion.

Released: November 16, 2023



Vivek Subbiah

Vivek Subbiah, MD

Chief, Early-Phase Drug Development
Sarah Cannon Research Institute
Nashville, Tennessee

Vamsidhar Velcheti

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

Provided by

Provided by Clinical Care Options, LLC in Partnership with the American Society for Clinical Pathology

ProCE Banner


Supported by an educational grant from Lilly.



American Society for Clinical Pathology

ProCE Banner